{"product_id":"9781118914342","title":"Attrition in the Pharmaceutical Industry: Reasons, Implications, and Pathways Forward","description":"\u003cp\u003eWith a focus on case studies of R\u0026amp;D programs in a variety of disease areas, the book highlights fundamental productivity issues the pharmaceutical industry has been facing and explores potential ways of improving research effectiveness and efficiency.\u003c\/p\u003e \u003cp\u003e• Takes a comprehensive and holistic approach to the problems and potential solutions to drug compound attrition\u003cbr\u003e• Tackles a problem that adds billions of dollars to drug development programs and health care costs\u003cbr\u003e• Guides discovery and development scientists through R\u0026amp;D stages, teaching requirements and reasons why drugs can fail\u003cbr\u003e• Discusses potential ways forward utilizing new approaches and opportunities to reduce attrition\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47121585701104,"sku":"9781118914342","price":135.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0737\/7593\/9824\/files\/9781118914342_p0.jpg?v=1769890053","url":"https:\/\/shop-qa.barnesandnoble.com\/products\/9781118914342","provider":"Barnes \u0026 Noble (DEV)","version":"1.0","type":"link"}